| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy
|
Scalone, Luciana
|
|
2016
|
19 |
5 |
p. 697-
1 p.
|
artikel
|
| 2 |
A Framework for Developing the Structure of Public Health Economic Models
|
Squires, Hazel
|
|
2016
|
19 |
5 |
p. 588-601
14 p.
|
artikel
|
| 3 |
A PROMIS Measure of Neuropathic Pain Quality
|
Askew, Robert L.
|
|
2016
|
19 |
5 |
p. 623-630
8 p.
|
artikel
|
| 4 |
Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis
|
Wang, Shi-Yi
|
|
2016
|
19 |
5 |
p. 631-638
8 p.
|
artikel
|
| 5 |
A Tale of Two Thresholds: A Framework for Prioritization within the Cancer Drugs Fund
|
Leigh, Simon
|
|
2016
|
19 |
5 |
p. 567-576
10 p.
|
artikel
|
| 6 |
Breakthrough Cancer Pain: Ten Commandments
|
Mercadante, Sebastiano
|
|
2016
|
19 |
5 |
p. 531-536
6 p.
|
artikel
|
| 7 |
Challenges in Measuring Cost and Value in Oncology: Making It Personal
|
Yu, Peter P.
|
|
2016
|
19 |
5 |
p. 520-524
5 p.
|
artikel
|
| 8 |
Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation
|
Fisher, Anat
|
|
2016
|
19 |
5 |
p. 688-696
9 p.
|
artikel
|
| 9 |
Clinical Guidelines: A NICE Way to Introduce Cost-Effectiveness Considerations?
|
Drummond, Michael
|
|
2016
|
19 |
5 |
p. 525-530
6 p.
|
artikel
|
| 10 |
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan
|
Shiroiwa, Takeru
|
|
2016
|
19 |
5 |
p. 648-654
7 p.
|
artikel
|
| 11 |
Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects
|
Hlatky, Mark A.
|
|
2016
|
19 |
5 |
p. 516-519
4 p.
|
artikel
|
| 12 |
Copyright/Subscription
|
|
|
2016
|
19 |
5 |
p. iv-
1 p.
|
artikel
|
| 13 |
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview
|
Garrison Jr., Louis P.
|
|
2016
|
19 |
5 |
p. 512-515
4 p.
|
artikel
|
| 14 |
Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales
|
Allen, Rachel
|
|
2016
|
19 |
5 |
p. 614-622
9 p.
|
artikel
|
| 15 |
Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy
|
Altawalbeh, Shoroq M.
|
|
2016
|
19 |
5 |
p. 537-543
7 p.
|
artikel
|
| 16 |
Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands
|
Silva, Maria Laura
|
|
2016
|
19 |
5 |
p. 670-679
10 p.
|
artikel
|
| 17 |
Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis
|
Kim, David D.
|
|
2016
|
19 |
5 |
p. 602-613
12 p.
|
artikel
|
| 18 |
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the “Optimal” Oral Anticoagulant for Atrial Fibrillation
|
Cameron, Christopher G.
|
|
2016
|
19 |
5 |
p. 661-669
9 p.
|
artikel
|
| 19 |
From the Co-Editors-In-Chief
|
|
|
2016
|
19 |
5 |
p. 511-
1 p.
|
artikel
|
| 20 |
Health or Happiness? A Note on Trading Off Health and Happiness in Rationing Decisions
|
van de Wetering, E.J.
|
|
2016
|
19 |
5 |
p. 552-557
6 p.
|
artikel
|
| 21 |
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group
|
Garfield, Susan
|
|
2016
|
19 |
5 |
p. 577-587
11 p.
|
artikel
|
| 22 |
How Many Alternatives Can Be Ranked? A Comparison of the Paired Comparison and Ranking Methods
|
Ock, Minsu
|
|
2016
|
19 |
5 |
p. 655-660
6 p.
|
artikel
|
| 23 |
Instructions for Authors
|
|
|
2016
|
19 |
5 |
p. I-IV
nvt p.
|
artikel
|
| 24 |
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
|
Vallejo-Torres, Laura
|
|
2016
|
19 |
5 |
p. 558-566
9 p.
|
artikel
|
| 25 |
Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C
|
Younossi, Zobair M.
|
|
2016
|
19 |
5 |
p. 544-551
8 p.
|
artikel
|
| 26 |
Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model: A Simulation Study
|
Doostfatemeh, Marziyeh
|
|
2016
|
19 |
5 |
p. 639-647
9 p.
|
artikel
|
| 27 |
Predicting the Burden of Revision Knee Arthroplasty: Simulation of a 20-Year Horizon
|
Guerrero-Ludueña, Richard E
|
|
2016
|
19 |
5 |
p. 680-687
8 p.
|
artikel
|
| 28 |
Table of Contents
|
|
|
2016
|
19 |
5 |
p. i-iii
nvt p.
|
artikel
|
Tijdschrift beschrijving